MoneyWorks4Me

Windlas Biotech informs about disclosure

04 May 2023 Evaluate
Windlas Biotech has informed regarding intimation of completion of Buyback by Windlas Biotech in terms of the provisions of Securities & Exchange Board of India (Buy Back of Securities) Regulations, 2018 (Buyback Regulations) through Open Market Route.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..